Primary Site >> Liver Cancer

Gene >> SOCS2

Journal: Hepatology. 2008 Apr;47(4):1191-9.
Title: Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.
Author: Martinez-Chantar, M Luz|Vazquez-Chantada, Mercedes|Ariz, Usue|Martinez, Nuria|Varela, Marta|Luka, Zigmund|Capdevila, Antonieta|Rodriguez, Juan|Aransay, Ana M|Matthiesen, Rune|Yang, Heping|Calvisi, Diego F|Esteller, Manel|Fraga, Mario|Lu, Shelly C|Wagner,
PMID: 18318442
Journal: Mol Cell Biochem. 2013 Jun;378(1-2):99-106.
Title: Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.
Author: Qiu, Xinyu|Zheng, Jianyong|Guo, Xiaodong|Gao, Xingchun|Liu, Hui|Tu, Yanyang|Zhang, Yongsheng
PMID: 23475171
Journal: J Viral Hepat. 2014 Apr;21(4):264-71.
Title: An integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma.
Author: Zhang, X|Wang, J|Cheng, J|Ding, S|Li, M|Sun, S|Zhang, L|Liu, S|Chen, X|Zhuang, H|Lu, F
PMID: 23941364
Journal: Front Endocrinol (Lausanne). 2014 Dec 18;5:218.
Title: Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice.
Author: Fan, Yong|Fang, Xin|Tajima, Asako|Geng, Xuehui|Ranganathan, Sarangarajan|Dong, Henry|Trucco, Massimo|Sperling, Mark A
PMID: 25566190
Journal: Tumour Biol. 2016 Oct;37(10):13521-13531.
Title: The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.
Author: Cui, Meiling|Sun, Ji|Hou, Jianjing|Fang, Tao|Wang, Xin|Ge, Chao|Zhao, Fangyu|Chen, Taoyang|Xie, Haiyang|Cui, Ying|Yao, Ming|Li, Jinjun|Li, Hong
PMID: 27465557
Journal: Sci Rep. 2017 May 11;7(1):1729.
Title: Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action.
Author: Yu, Yi|Wan, Pin|Cao, Yanhua|Zhang, Wei|Chen, Junbo|Tan, Li|Wang, Yan|Sun, Zhichen|Zhang, Qi|Wan, Yushun|Zhu, Ying|Liu, Fang|Wu, Kailang|Liu, Yingle|Wu, Jianguo
PMID: 28496097
Journal: Sci Rep. 2017 Jul 17;7(1):5517.
Title: Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma.
Author: Li, Binghua|Feng, Wendu|Luo, Ouyang|Xu, Tiancheng|Cao, Yajuan|Wu, Hongyan|Yu, Decai|Ding, Yitao
PMID: 28717245
Journal: J Exp Clin Cancer Res. 2017 Jul 27;36(1):99.
Title: miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma.
Author: Jiang, Chunlin|Long, Jianting|Liu, Baoxian|Xu, Ming|Wang, Wei|Xie, Xiaoyan|Wang, Xiaolin|Kuang, Ming
PMID: 28750679
Journal: Hepatology. 2018 Jun;67(6):2254-2270.
Title: RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Author: Chen, Mengnuo|Wei, Lai|Law, Cheuk-Ting|Tsang, Felice Ho-Ching|Shen, Jialing|Cheng, Carol Lai-Hung|Tsang, Long-Hin|Ho, Daniel Wai-Hung|Chiu, David Kung-Chun|Lee, Joyce Man-Fong|Wong, Carmen Chak-Lui|Ng, Irene Oi-Lin|Wong, Chun-Ming
PMID: 29171881
Journal: Cancer Lett. 2018 Jun 1;423:113-126.
Title: Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling.
Author: Long, Jianting|Jiang, Chunlin|Liu, Baoxian|Dai, Qiangsheng|Hua, Ruixi|Chen, Cui|Zhang, Bing|Li, Heping
PMID: 29196128
Journal: Oncol Lett. 2018 Sep;16(3):3183-3192.
Title: Potential biomarkers of HCC based on gene expression and DNA methylation profiles.
Author: Meng, Chao|Shen, Xiaomin|Jiang, Wentao
PMID: 30127913